Molecular Detection of Human Coronavirus from North Central Part of Bangladesh Depending on ORF1ab and N Gene.
Adult
Aged
Bangladesh
/ epidemiology
Betacoronavirus
COVID-19
China
Clinical Laboratory Techniques
Coronavirus
Coronavirus Infections
Coronavirus Nucleocapsid Proteins
Humans
Male
Middle Aged
Nucleocapsid Proteins
Pandemics
Phosphoproteins
Pneumonia, Viral
SARS-CoV-2
Viral Regulatory and Accessory Proteins
Journal
Mymensingh medical journal : MMJ
ISSN: 2408-8757
Titre abrégé: Mymensingh Med J
Pays: Bangladesh
ID NLM: 9601799
Informations de publication
Date de publication:
Oct 2020
Oct 2020
Historique:
entrez:
29
10
2020
pubmed:
30
10
2020
medline:
31
10
2020
Statut:
ppublish
Résumé
The Coronavirus disease 2019 (COVID-19) resulted severe respiratory illness such as pneumonia and lung dysfunctions that was first identified at Wuhan, the capital of Hubeiin China during the end of December 2019. The etiological cause of COVID-19 has been confirmed as a novel coronavirus known as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) which was similar with the zoonotic virus SARS-CoV (2002). Now a days for early diagnosis of COVID-19 the nucleic acid based test like RT PCR (real time reverse transcription polymerase chain reaction) is most consistent and used all over the world. In this study among 11,280 cases 825(7.31%) were positive by molecular RT PCR method on June 2020 at Microbiology department of Mymensingh Medical College and the samples are collected from different areas of Northern part of Bangladesh. Among this positive cases 588(71%) N gene, 10 ORF1ab (2%) and 227(27%) both N and ORF gene showed significant curve which is specific for COVID-19 positive patients. Because N and ORF gene of this virus inhibit immune system of human body especially interferon. Out of SARS-CoV-2 positive cases maximum number of N gene were found in male patients and above 40 years old aged group. So, Molecular diagnosis of this pandemic virus especially by N and ORF gene might be helpful to reduce the spread of SARS-CoV-2 as well as early treatment for saving many lives.
Substances chimiques
Coronavirus Nucleocapsid Proteins
0
Nucleocapsid Proteins
0
Phosphoproteins
0
Viral Regulatory and Accessory Proteins
0
nucleocapsid phosphoprotein, SARS-CoV-2
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM